Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog

Xinmei Wang, Hongyan He, Yuanzhi Lu, Wei Ren, Kun yu Teng, Chi ling Chiang, Zhaogang Yang, Bo Yu, Shuhao Hsu, Samson T. Jacob, Kalpana Ghoshal, L. James Lee

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A major obstacle to successful treatment of hepatocellular carcinoma (HCC) is its high resistance to cytotoxic chemotherapy due to overexpression of multidrug resistance genes. Activation of the AKT pathway is known to be involved in chemoresistance in HCC; however, the underlying mechanisms modulating the AKT pathway by chemopreventive agents remain unclear. In the present study, we found that indole-3-carbinol (I3C) treatment for tumor cells repressed the AKT pathway by increasing the expression of phosphatase and tensin homolog (PTEN) in HCC xenograft tumor and HCC cell lines. qRT-PCR data showed that the expression of miR-21 and miR-221&222 was significantly reduced by I3C in HCC cells in vitro and in vivo. Reactivation of the AKT pathway via restoration of miR-21 was reversed by I3C. Ectopic expression of miR-21 mediated-accelerated wound healing was abrogated by I3C. Moreover, reducing the expression of miR-21 by anti-miR decreased the resistance of HCC cells to I3C. These results provide experimental evidences that I3C could function as a miR-21 regulator, leading to repression of the PTEN/AKT pathway and opening a new avenue for eradication of drug-resistant cells, thus potentially helping to improve the therapeutic outcome in patients diagnosed with HCC.

Original languageEnglish (US)
Pages (from-to)244-253
Number of pages10
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1853
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

MicroRNAs
Phosphoric Monoester Hydrolases
Hepatocellular Carcinoma
Up-Regulation
MDR Genes
indole-3-carbinol
Tensins
Heterografts
Wound Healing
Neoplasms
Therapeutics
Drug Therapy
Cell Line
Polymerase Chain Reaction
Pharmaceutical Preparations

Keywords

  • Hepatocellular carcinoma
  • Indole-3-carbinol
  • MiR-21
  • MiR-221&222
  • PTEN

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. / Wang, Xinmei; He, Hongyan; Lu, Yuanzhi; Ren, Wei; Teng, Kun yu; Chiang, Chi ling; Yang, Zhaogang; Yu, Bo; Hsu, Shuhao; Jacob, Samson T.; Ghoshal, Kalpana; Lee, L. James.

In: Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1853, No. 1, 01.01.2015, p. 244-253.

Research output: Contribution to journalArticle

Wang, Xinmei ; He, Hongyan ; Lu, Yuanzhi ; Ren, Wei ; Teng, Kun yu ; Chiang, Chi ling ; Yang, Zhaogang ; Yu, Bo ; Hsu, Shuhao ; Jacob, Samson T. ; Ghoshal, Kalpana ; Lee, L. James. / Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. In: Biochimica et Biophysica Acta - Molecular Cell Research. 2015 ; Vol. 1853, No. 1. pp. 244-253.
@article{78109d5b8d5a4d569ac71a507a331e75,
title = "Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog",
abstract = "A major obstacle to successful treatment of hepatocellular carcinoma (HCC) is its high resistance to cytotoxic chemotherapy due to overexpression of multidrug resistance genes. Activation of the AKT pathway is known to be involved in chemoresistance in HCC; however, the underlying mechanisms modulating the AKT pathway by chemopreventive agents remain unclear. In the present study, we found that indole-3-carbinol (I3C) treatment for tumor cells repressed the AKT pathway by increasing the expression of phosphatase and tensin homolog (PTEN) in HCC xenograft tumor and HCC cell lines. qRT-PCR data showed that the expression of miR-21 and miR-221&222 was significantly reduced by I3C in HCC cells in vitro and in vivo. Reactivation of the AKT pathway via restoration of miR-21 was reversed by I3C. Ectopic expression of miR-21 mediated-accelerated wound healing was abrogated by I3C. Moreover, reducing the expression of miR-21 by anti-miR decreased the resistance of HCC cells to I3C. These results provide experimental evidences that I3C could function as a miR-21 regulator, leading to repression of the PTEN/AKT pathway and opening a new avenue for eradication of drug-resistant cells, thus potentially helping to improve the therapeutic outcome in patients diagnosed with HCC.",
keywords = "Hepatocellular carcinoma, Indole-3-carbinol, MiR-21, MiR-221&222, PTEN",
author = "Xinmei Wang and Hongyan He and Yuanzhi Lu and Wei Ren and Teng, {Kun yu} and Chiang, {Chi ling} and Zhaogang Yang and Bo Yu and Shuhao Hsu and Jacob, {Samson T.} and Kalpana Ghoshal and Lee, {L. James}",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.bbamcr.2014.10.017",
language = "English (US)",
volume = "1853",
pages = "244--253",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog

AU - Wang, Xinmei

AU - He, Hongyan

AU - Lu, Yuanzhi

AU - Ren, Wei

AU - Teng, Kun yu

AU - Chiang, Chi ling

AU - Yang, Zhaogang

AU - Yu, Bo

AU - Hsu, Shuhao

AU - Jacob, Samson T.

AU - Ghoshal, Kalpana

AU - Lee, L. James

PY - 2015/1/1

Y1 - 2015/1/1

N2 - A major obstacle to successful treatment of hepatocellular carcinoma (HCC) is its high resistance to cytotoxic chemotherapy due to overexpression of multidrug resistance genes. Activation of the AKT pathway is known to be involved in chemoresistance in HCC; however, the underlying mechanisms modulating the AKT pathway by chemopreventive agents remain unclear. In the present study, we found that indole-3-carbinol (I3C) treatment for tumor cells repressed the AKT pathway by increasing the expression of phosphatase and tensin homolog (PTEN) in HCC xenograft tumor and HCC cell lines. qRT-PCR data showed that the expression of miR-21 and miR-221&222 was significantly reduced by I3C in HCC cells in vitro and in vivo. Reactivation of the AKT pathway via restoration of miR-21 was reversed by I3C. Ectopic expression of miR-21 mediated-accelerated wound healing was abrogated by I3C. Moreover, reducing the expression of miR-21 by anti-miR decreased the resistance of HCC cells to I3C. These results provide experimental evidences that I3C could function as a miR-21 regulator, leading to repression of the PTEN/AKT pathway and opening a new avenue for eradication of drug-resistant cells, thus potentially helping to improve the therapeutic outcome in patients diagnosed with HCC.

AB - A major obstacle to successful treatment of hepatocellular carcinoma (HCC) is its high resistance to cytotoxic chemotherapy due to overexpression of multidrug resistance genes. Activation of the AKT pathway is known to be involved in chemoresistance in HCC; however, the underlying mechanisms modulating the AKT pathway by chemopreventive agents remain unclear. In the present study, we found that indole-3-carbinol (I3C) treatment for tumor cells repressed the AKT pathway by increasing the expression of phosphatase and tensin homolog (PTEN) in HCC xenograft tumor and HCC cell lines. qRT-PCR data showed that the expression of miR-21 and miR-221&222 was significantly reduced by I3C in HCC cells in vitro and in vivo. Reactivation of the AKT pathway via restoration of miR-21 was reversed by I3C. Ectopic expression of miR-21 mediated-accelerated wound healing was abrogated by I3C. Moreover, reducing the expression of miR-21 by anti-miR decreased the resistance of HCC cells to I3C. These results provide experimental evidences that I3C could function as a miR-21 regulator, leading to repression of the PTEN/AKT pathway and opening a new avenue for eradication of drug-resistant cells, thus potentially helping to improve the therapeutic outcome in patients diagnosed with HCC.

KW - Hepatocellular carcinoma

KW - Indole-3-carbinol

KW - MiR-21

KW - MiR-221&222

KW - PTEN

UR - http://www.scopus.com/inward/record.url?scp=84909992179&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909992179&partnerID=8YFLogxK

U2 - 10.1016/j.bbamcr.2014.10.017

DO - 10.1016/j.bbamcr.2014.10.017

M3 - Article

C2 - 25447674

AN - SCOPUS:84909992179

VL - 1853

SP - 244

EP - 253

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 1

ER -